Search

everythinglearnresearchcommunity

for

Search:↓

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Dermoscopy is useful for tracking alopecia areata treatment, with yellow dots and new vellus hairs being good indicators of hair regrowth.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Certain hair and scalp features can predict the severity of alopecia areata.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

ODAC members faced intense pressure but prioritized scientific evidence in drug approval decisions.

The model improves understanding of androgen interactions by focusing on signal intensity and system capacity.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

The CWARTS tool is a promising method for assessing warts and could improve treatment and research.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Baricitinib shows promise in treating severe hair loss.

Patients and doctors often agree on the severity of eyebrow and eyelash hair loss in severe alopecia areata.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

VESALT improves alopecia areata assessment by including non-scalp areas and is reliable and user-friendly.

Baricitinib is effective for severe alopecia areata but has some side effects.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.